Dominick, K. C., Andrews, H. F., Kaufmann, W. E., Berry-Kravis, E., & Erickson, C. A. (2021). Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology, 31(10), 659–669. https://doi.org/10.1089/cap.2021.0042

Neuhaus, E., Lowry, S. J., Santhosh, M., Kresse, A., Edwards, L. A., Keller, J., Libsack, E. J., Kang, V. Y., Naples, A., Jack, A., Jeste, S., McPartland, J. C., Aylward, E., Bernier, R., Bookheimer, S., Dapretto, M., Van Horn, J. D., Pelphrey, K., & Webb, S. J. (2021). Resting state EEG in youth with ASD: age, sex, and relation to phenotype. Journal of Neurodevelopmental Disorders, 13(1). https://doi.org/10.1186/s11689-021-09390-1

Cheslack‐Postava, K., Sourander, A., Hinkka‐Yli‐Salomäki, S., McKeague, I. W., Surcel, H., & Brown, A. S. (2021). A biomarker‐based study of prenatal smoking exposure and autism in a Finnish national birth cohort. Autism Research, 14(11), 2444–2453. Portico. https://doi.org/10.1002/aur.2608

Blanchard, A., Chihuri, S., DiGuiseppi, C. G., & Li, G. (2021). Risk of Self-harm in Children and Adults With Autism Spectrum Disorder. JAMA Network Open, 4(10), e2130272. https://doi.org/10.1001/jamanetworkopen.2021.30272

Brunson McClain, M., Roanhorse, T. T., Harris, B., Heyborne, M., Zemantic, P. K., & Azad, G. (2021). School-based autism evaluations in the COVID-19 era. School Psychology, 36(5), 377–387. https://doi.org/10.1037/spq0000447

Zwaigenbaum, L., Bishop, S., Stone, W. L., Ibanez, L., Halladay, A., Goldman, S., Kelly, A., Klaiman, C., Lai, M., Miller, M., Saulnier, C., Siper, P., Sohl, K., Warren, Z., & Wetherby, A. (2021). Rethinking autism spectrum disorder assessment for children during COVID‐19 and beyond. Autism Research, 14(11), 2251–2259. Portico. https://doi.org/10.1002/aur.2615